Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference
CARLSBAD, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that João Siffert, M.D., president and chief executive officer, and Sean Jeffries, Ph.D., chief operating officer, will participate in a fireside chat during the 2022 Wedbush PacGrow Virtual Healthcare Conference on Wednesday, August 10, 2022, at 10:20 a.m. ET.
A live webcast will be available in the investor section of the company's website at www.designtx.com. The webcast will be arcived for 30 days following the presentation.
About Design Therapeutics